Prof. Dr. Martin Fromm

Lehrstuhl für Klinische Pharmakologie und Klinische Toxikologie

Novel drug transporter substrates identification: An innovative approach based on metabolomic profiling, in silico ligand screening and biological validation (2023) Nies AT, König J, Leuthold P, Damme K, Winter S, Haag M, Masuda S, et al. Journal article The Prevalence of Potentially Inappropriate Medication in Geriatric Inpatients According to the PRISCUS 2.0 List (2023) Then M, Deutsch B, Tümena T, Thürmann PA, Fromm M, Gaßmann KG, Maas R Journal article Optimizing Medication Safety with Oral Antitumor Therapy: A Methodological Approach for the Real-World Implementation of the AMBORA Competence and Consultation Center (2023) Cuba L, Schlichtig K, Dürr P, Inwald EC, Fromm M, Dörje F Journal article Inconsistencies of absolute drug-drug contraindication reports: Analysis of Summaries of Product Characteristics of commonly prescribed drugs (2023) Weisbach L, Schuster AK, Hartmann M, Dürr P, Then M, Andrikyan W, Fromm M, et al. Journal article, Original article Transcriptional Regulation of Liver-Type OATP1B3 (Lt-OATP1B3) and Cancer-Type OATP1B3 (Ct-OATP1B3) Studied in Hepatocyte-Derived and Colon Cancer-Derived Cell Lines (2023) Haberkorn B, Löwen D, Meier L, Fromm M, König J Journal article Cold Atmospheric Plasma Triggers Apoptosis via the Unfolded Protein Response in Melanoma Cells (2023) Zimmermann T, Stäbler S, Taudte RV, Ünüvar S, Groesch S, Arndt S, Karrer S, et al. Journal article Development in Prescriptions of Contraindicated and Potentially Harmful QT Interval-Prolonging Drugs in a Large Geriatric Inpatient Cohort From 2011 to 2021 (2023) Then M, Tuemena T, Sledziewska A, Gassmann KG, Maas R, Fromm M Journal article, Original article A supervised machine-learning approach for the efficient development of a multi method (LC-MS) for a large number of drugs and subsets thereof: Focus on oral antitumor agents (2023) Kehl N, Geßner A, Maas R, Fromm M, Taudte V Journal article Exploring Structural Determinants of Bias among D4 Subtype-Selective Dopamine Receptor Agonists (2023) Graßl F, Bock L, Huete-Huerta González Á, Schiller M, Gmeiner P, König J, Fromm M, et al. Journal article N1-Methylnicotinamide as Biomarker for MATE-Mediated Renal Drug–Drug Interactions: Impact of Cimetidine, Rifampin, Verapamil, and Probenecid (2023) Müller F, Hohl K, Keller S, Schmidt-Gerets S, Deutsch B, Schuler-Metz A, Fromm M, et al. Journal article